Organization
Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Rep. of (South Korea)
3 abstracts
Abstract
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 EQUIVALENCE TRIAL COMPARING THE ETANERCEPT BIOSIMILAR, HD203, WITH ENBREL®, IN COMBINATION WITH METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) Org: Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Rep. of (South Korea), Jeju National University Hospital, Jeju, Catholic University of Daegu, Daegu, IN-HA University Hospital, Incheon, Hanwha Chemical, Seoul,
Abstract
A PHASE 3, OPEN-LABEL, CONTINUATION STUDY EVALUATING LONG-TERM SAFETY AND EFFICACY OF BELIMUMAB IN PATIENTS FROM JAPAN AND KOREA WITH SYSTEMIC LUPUS ERYTHEMATOSUS, FOR UP TO 7 YEARSOrg: University of Occupational and Environmental Health, Kitakyushu, Japan, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Rep. of (South Korea), GlaxoSmithKline, Collegeville, United States of America, GlaxoSmithKline (at the time of the study), Collegeville, United States of America, GlaxoSmithKline, Uxbridge, United Kingdom,
Abstract
ASSOCIATIONS BETWEEN EXTRA-MUSCULOSKELETAL MANIFESTATIONS AND RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITISOrg: Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom, Department of Medical and Molecular Genetics, King’s College London, London, United Kingdom, Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, Australia, Department of Medicine, Division of Rheumatology, University of California, San Francisco, United States of America, School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China,